NOX 9.52% 11.5¢ noxopharm limited

IONIC may yet be a winner, page-31

  1. 604 Posts.
    lightbulb Created with Sketch. 361
    Uncertainty? Oh, I'm pretty certain the SP is headed to 1c.

    The evidence keeps mounting.

    It looks like the CEP-2 trial is now "ON HOLD" in the USA: https://www.froedtert.com/clinical-trials/cancer/dose-escalation-and-dose-expansion-study-nox66-plus-doxorubicin

    And overnight, the IONIC patent was hit with a FINAL REJECTION:
    https://patentcenter.uspto.gov/applications/17324927/ifw/docs


 
watchlist Created with Sketch. Add NOX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.